Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists. 1999

P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
Dipartimento di Scienze Farmaceutiche, Dipartimento di Medicina, Clinica e Sperimentale-Sezione di Farmacologia, Università degli Studi di Ferrara, Via Fossato di Mortara 17-19, I-44100 Ferrara, Italy. pgb@dns.unife.it

UI MeSH Term Description Entries
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016466 CHO Cells CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells. CHO Cell,Cell, CHO,Cells, CHO

Related Publications

P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
March 2007, Bioorganic & medicinal chemistry letters,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
June 2012, Journal of medicinal chemistry,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
January 2011, Bioorganic & medicinal chemistry letters,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
October 2013, Archiv der Pharmazie,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
January 2012, Bioorganic & medicinal chemistry,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
April 2011, Bioorganic & medicinal chemistry letters,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
January 2016, Current topics in medicinal chemistry,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
July 2015, Journal of medicinal chemistry,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
February 2009, Bioorganic & medicinal chemistry letters,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and K N Klotz, and E Leung, and K Varani, and S Gessi, and S Merighi, and P A Borea
October 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!